Associations lobby WHO to build COVID-19 IP pool

Numerous associations and individuals have come together to ask the World Health Organization (WHO) to build a global pool for IP rights related to the COVID-19 pandemic.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

COVID-19 spurs medical and pharma rise in ‘Top 100 Global Innovators’ report

23 February 2021 Innovation by medical and pharma sectors has increased over the past year in the wake of the pandemic, a new report by IP services company Clarivate has confirmed.

Americas

Allied BioScience sues ex-CEO for holding IP hostage

12 November 2020 Allied BioScience has accused its former CEO of holding the company's IP, including inventions relating to its COVID-19 antiviral disinfectant, to ransom so he can demand an unfair amount of compensation.

Big Pharma

European Commission's first deal for COVID-19 vaccine takes effect

1 September 2020 The European Commission’s first ever contract to secure a COVID-19 vaccine came into force on August 27, after it signed a deal with pharmaceutical company AstraZeneca.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Associations lobby WHO to build COVID-19 IP pool

More on this story

Editor's picks

Editor's picks

More features